NRC — NRC HEALTH
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 70487 ·
Last close
$21.92
Market Cap
$485.29M
52W High
$23.68
52W Low
$17.21
ADV30
116,003
Next earnings
2026-10-26
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 35,194,000 | 21,259,000 | 4,669,000 | 1,798,000 | 134,878,000 | 4,139,000 | 120,888,000 |
| Sep 2025 | 34,608,000 | 22,204,000 | 7,738,000 | 4,122,000 | 135,719,000 | 2,219,000 | 121,405,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$29,509,000
Investing CF
$-7,868,000
Financing CF
$-23,588,000
CapEx
$-7,868,000
Dividends Paid
$-12,705,000
Buybacks
$-18,848,000
EPS Diluted TTM
$0.25
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-24,507,000
Inventory
—
Receivables
$13,649,000
ST Investments
—
EBIT TTM
$14,789,000
Pretax Income TTM
$9,384,000
Interest Exp TTM
$5,405,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$139,996,992
EBITDA
$26,675,000
Free Cash Flow
$20,282,000
Enterprise Value
$577,952,192
Total Cash
$3,327,000
Total Debt
$90,446,000
Shares Out
22,139,315
Trailing EPS
$0.24
Book Value
$0.30
ROE
42.0%
ROA
8.1%
Div Yield
2.89%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 137,390,000 | 22,590,000 | 11,600,000 | 134,878,000 | 120,888,000 | — | 26,450,000 |
| Dec 2024 | 143,060,000 | 35,194,000 | 24,783,000 | 132,539,000 | 101,255,000 | — | 34,625,000 |
| Dec 2023 | 148,580,000 | 40,045,000 | 30,971,000 | 122,437,000 | 73,482,000 | — | 38,113,000 |
| Dec 2022 | 151,568,000 | 46,543,000 | 31,800,000 | 130,461,000 | 58,428,000 | — | 36,265,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.05
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $20.00 · spot: $21.92 · call volume: 667 · put volume: 2Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TKNO | Alpha Teknova, Inc. | $394.07M | $7.34 | — |
| NNNN | Anbio Biotechnology | $346.74M | $7.90 | — |
| OABI | OmniAb, Inc. | $684.79M | $4.71 | — |
| MYGN | MYRIAD GENETICS INC | $291.73M | $3.05 | — |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $817.05M | $7.94 | — |
News headlines (Yahoo Finance, 1h cache)
New NRC Health Research Reveals What Drives Patient Loyalty Beyond Access
2026-07-30 13:00 · Yahoo
NRC Health (NRC) Q2 2026 Earnings Call Highlights: Strong TRCV Growth Amid Market Uncertainty
2026-07-29 05:01 · Yahoo
Resideo Appoints Shane Harrison as Chief Financial Officer
2026-08-12 20:06 · Yahoo
Record Backlog Powers NRC Health’s (NRC) Upward Potential
2026-08-10 15:34 · Yahoo
NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth
2026-08-03 17:53 · Yahoo
National Research Q2 Earnings Call Highlights
2026-07-28 22:04 · Yahoo
TSX Penny Stocks To Watch In June 2026
2026-06-10 13:05 · Yahoo
NRC Health and Healthcare Experience Foundation Launch Strategic Partnership to Deepen Support for Improving Experience, Safety, and Workforce Engagement
2026-06-09 13:00 · Yahoo
President of Nations Royalty Derrick Pattenden Buys 93% More Shares
2026-05-30 14:17 · Yahoo
There May Be Reason For Hope In NRC Health's (NASDAQ:NRC) Disappointing Earnings
2026-05-13 10:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.